This trial is evaluating whether Treatment will improve 1 primary outcome and 9 secondary outcomes in patients with Fibromyalgia. Measurement will happen over the course of Baseline to Week 12.
This trial requires 500 total participants across 0 different treatment group
Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.
In order to understand how insurance coverage works for this trial, you will need to contact the study coordinator.